Unanswered questions--drug-eluting stents and the risk of late thrombosis.
Maisel
William H
WH
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA.
D015906:Angioplasty, Balloon, Coronary; D003327:Coronary Disease / Q000401:mortality / Q000628:therapy*; D003328:Coronary Thrombosis / Q000209:etiology*; D018795:Device Approval; D016503:Drug Delivery Systems; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology; D017239:Paclitaxel / Q000008:administration & dosage; D011474:Prosthesis Design; D011475:Prosthesis Failure; D012306:Risk; D020123:Sirolimus / Q000008:administration & dosage; D015607:Stents / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D017239:Paclitaxel; D020123:Sirolimus